Print this page    •   Back to Web version of article

U.S. News
Federal Appeals Court Rejects Lawsuit Against Abbott Over HIV/AIDS Drug Price Hike

July 8, 2009

A federal appeals court on Tuesday rejected a lawsuit against Abbott Laboratories accusing the company "of antitrust violations over a sudden 400-percent price hike of a popular AIDS drug," the AP/El Paso Times reports (7/7). Advocacy groups and drug benefit providers sued Abbott in 2004 alleging the "drugmaker raised the price of the HIV-fighting Norvir to stifle competition and boost sales of its own alternative, Kaletra. The company paid $10 million to settle the lawsuit and agreed to let the 9th U.S. Circuit Court of Appeals still determine if the price hike was an illegal business practice," writes AP/Minneapolis Star Tribune. A lawyer for the advocacy groups says they are still deciding whether to file an appeal (7/7).

Back to other news for July 2009


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily U.S. HIV/AIDS Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art52616.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.